This study tested whether an oral drug called NG101 can reduce gastrointestinal side effects (like nausea and vomiting) caused by GLP-1 weight-loss medications such as semaglutide. 120 healthy adults with a BMI between 22 and 35 took either NG101 or a placebo for five days, and r…
Phase: PHASE2 • Sponsor: Neurogastrx, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 13:29 UTC